A clinical study of the safety and efficacy of sclerotherapy in patients with venous malformatio
Not Applicable
- Conditions
- venous malformation
- Registration Number
- JPRN-UMIN000010320
- Lead Sponsor
- Plastic and Reconstructive Surgery, School of Medicine, Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Those who are allergic to iodinated contrast material or polidocanol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are targeted by sclerotherapy agents in venous malformation treatment?
How does sclerotherapy compare to laser therapy for venous malformation recurrence rates?
Which biomarkers correlate with long-term response to sclerotherapy in venous malformations?
What are the most common adverse events reported in sclerotherapy trials for vascular anomalies?
Are there combination therapies with sclerotherapy improving outcomes in complex venous malformations?